Evidence map›Paper›PMID 31292251›Full record

ArticleJournal of virology2019

LAP

Laura María Rey, José Ángel Gil, José Mateus, Luz-Stella Rodríguez, Martín Alonso Rondón, Juana Ángel, Manuel Antonio Franco

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Laura María ReyInstituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia.
José Ángel GilInstituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia.
José MateusDepartment of Microbiology, Pontificia Universidad Javeriana, Bogotá, Colombia.
Luz-Stella RodríguezInstituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia.
Martín Alonso RondónDepartment of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Bogotá, Colombia.
Juana ÁngelInstituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia.
Manuel Antonio FrancoInstituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia mafranco@javeriana.edu.co.ORCID 0000-0002-0265-0563
Pontificia Universidad Javeriana · CO

Funding

NIAID NIH HHS HHSN272201300006C
6 · The paper itself

Abstract

Transforming growth factor β (TGF-β) has been shown to play a role in immunity against different pathogens

Indexed as

Administration, OralAnimalsAnimals, NewbornCD4-Positive T-LymphocytesDiarrheaDisease Models, AnimalImmunity, HeterologousMiceRotavirus InfectionsRotavirus VaccinesT-Lymphocyte SubsetsTransforming Growth Factor betaTreatment Outcomerhesus rotavirus vaccineRotavirus VaccinesTransforming Growth Factor betaintestinelatency-associated peptideneonatal micerotavirustransforming growth factor βvaccine

Identifiers

PMID31292251
PMCPMC6744246
OpenAlexW2959834398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.